Neurologic clinical trial - LT3001-205

Status:

Open/Enrolling

ClinicalTrials.gov:

NCT05403866

 LT3001-205

Drug

LT3001

Phase

Phase II

Condition

Acute Ischemic Stroke

Keywords

Acute Ischemic Stroke